Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (Listing obligations and Disclosure requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company will be held on Saturday, 07th November, 2026, at corporate office of the company at 5TH Floor, 501 SAKAR ....

Date: 04th November, 2026 BSE Limited, Floor 25, P J Towers, Dalal Street, Mumbai – 400001 Script Code: 543963 ISIN: INE013V01011 Subject: Intimation of Board Meeting to be held on day 07th November, 2026. Dear Sir/Madam, Pursuant to Regulation 29(1)(a) of SEBI (Listing obligations and Disclosure requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company will be held on Saturday, 07th November, 2026, at corporate office of the company at 5TH Floor, 501 SAKAR 4, Opp. Town Hall, Ashram Road, Ahmedabad, Gujarat -380006, inter-alia, to consider the following agendas: 1. To consider, approve and take on record the Un-audited Financial Results for the Half year ended on September 30, 2026 as per Regulation 33 of the SEBI (LODR) Regulation, 2015 along with Limited Review report on above Financial Results; 2. Such Other agendas as may be considered necessary with the permission of the chair. Further, the trading window, which was earlier intimated in connection with the said Board Meeting, shall remain closed until 48 hours after the declaration / publication of the Financial Results for the Half year ended on September 30, 2026 which will be now till Monday, November, 09 2026. The above Board meeting Intimation will be made available on website of the Company at https://shelter.co.in. Kindly take the above on record and oblige. Thanking You. FOR, SHELTER PHARMA LIMITED MUSTAQIM NISARAHMED SABUGAR CHAIRMAN & MANAGING DIRECTOR DIN: 01456841